Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications in Hematology
Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect ® MM Registry (2010–2016)
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Loss of TRIM62 Expression Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Prognosis of Primary Myelofibrosis in the Genomic Era
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
High Pseudotumor Cerebri Incidence in Tretinoin and Arsenic Treated Acute Promyelocytic Leukemia and the Role of Topiramate After Acetazolamide Failure
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Ruxolitinib for Myelofibrosis–An Update of Its Clinical Effects
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Progress in Novel Cellular Therapy Options for Chronic Lymphocytic Leukemia: The MD Anderson Perspective
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
‹
617
618
619
620
621
622
623
›
